Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 233.6 INR -6.25%
Market Cap: 21.5B INR

INDOCO's latest stock split occurred on May 17, 2012

The company executed a 5-for-1 stock split, meaning that for every share held, investors received 5 new shares.

The adjusted shares began trading on May 17, 2012. This was the only stock split in INDOCO's history.

Last Splits:
May 17, 2012
5-for-1
Pre-Split Price
N/A
Post-Split Price
51.24
Before
After
Last Splits:
May 17, 2012
5-for-1

Indoco Remedies Ltd
Stock Splits History

INDOCO Stock Splits Timeline
May 17, 2012
May 17, 2012
Split 5-for-1
x5
Pre-Split Price
N/A
Post-Split Price
51.24
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 1, 2025
I
Icon Energy Corp
NASDAQ:ICON
1-for-40
/40
0.0478 1.912 USD 1.79 1.79 USD
Apr 1, 2025
V
Vortex Energy Corp
CNSX:VRTX
1-for-10
/10
0.075 0.75 CAD 0.11 0.11 CAD
Apr 1, 2025
R
Resource Centrix Holdings Inc
CNSX:RECE
10-for-1
x10
2.4 0.24 CAD 0.24 0.24 CAD
Apr 1, 2025
V
Vortex Energy Corp
OTC:VTECF
1-for-10
/10
0.05 0.5 USD 0.0378 0.0378 USD
Mar 31, 2025
Utime Ltd
NASDAQ:WTO
1-for-10
/10
0.151 1.51 USD 1.58 1.58 USD
Load More

Indoco Remedies Ltd
Glance View

Market Cap
21.5B INR
Industry
Pharmaceuticals

Indoco Remedies Ltd. engages in manufacturing and marketing of Formulations (Finished Dosage Forms) and active pharmaceutical ingredients. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2005-01-07. The firm is an integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The firm's geographical segments include India and Outside India. The firm has nine domestic marketing divisions with a brand portfolio in various therapeutic segments, including Gastrointestinal, Respiratory, Anti-Infective, Stomatologicals, Ophthalmic, Nutritionals, Cardiovascular, Anti-Diabetics, Pain Management and Gyneacology. The Company’s brands include Cyclopam, Febrex Plus, Sensodent-K, Karvol Plus, ATM, Oxipod, Cital, Sensoform, Sensodent-KF, Cal-Aid, Cloben-G, Glychek, Kidodent, Carmicide, Rexidin, MCBM and Methycal.

INDOCO Intrinsic Value
344.77 INR
Undervaluation 32%
Intrinsic Value
Price
What is Intrinsic Value?
Back to Top
ALPHA SPREAD
Follow us
Join more than 244,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.